Skip to content

oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study

oneKNEE - Prospective, Non-interventional, Multicenter Post-Market Clinical Follow-Up Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07682909
Acronym
oneKNEE
Enrollment
1020
Registered
2026-07-06
Start date
2027-04-01
Completion date
2031-12-01
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Arthroplasty Replacement, Knee, Prosthetic Joint Infections of Knee, TKA Outcomes

Keywords

Total Knee Arthroplasty, Safety and Clinical Performance, oneKnee, Integrated platform of knee implants and instruments

Brief summary

Safety and Clinical Performance in terms of clinical outcome of oneKNEE® (total knee arthroplasty TKA), evaluated 2 years after implantation.

Detailed description

Safety and Clinical Performance will be observed: Safety: All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure. Clinical Performance: Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state.

Interventions

DEVICEoneKNEE®

Total knee prostheses

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Patient age ≤ 80 years * Indication for a total knee replacement with one of the variants * Written informed consent * Willingness and mental ability to participate at the long-term follow-up examinations

Exclusion criteria

* Contraindications acc. to the Instructions for Use (IFU) * Patient age \< 18 years * Known pregnancy * BMI \> 40 * Secondary gonarthrosis (e.g. rheumatoid arthritis, post-traumatic) * Patients classified as high risk (ASA class \>3) * Patients with immunodeficiency, i.e. patients currently receiving immunosuppressive therapy or patients with severe immunodeficiency requiring drug therapy * Preoperative: aHKA \> 190° or aHKA \< 170° * Preoperative: aHKA \> 190° or aHKA \< 170°\[KB1.1\]\[HO1.2\]\[KB1.3\]\[HO1.4\] * Patients held in a custodial setting und - Patients in a relationship of dependence on the sponsor, the clinic or the investigator

Design outcomes

Primary

MeasureTime frameDescription
Safety of the implant2 years after implantationSafety in terms of clinical outcome of oneKNEE® All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.
Clinical Performance in terms of clinical outcome of oneKNEE®2 years after implantationClinical Performance in terms of clinical outcome of oneKNEE®. Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state. The Oxford Knee Score (OKS) is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome.

Secondary

MeasureTime frameDescription
Clinical Outcome by evaluating the Oxford Knee ScoreV4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OPThe Oxford Knee Score, OKS is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome.
Evaluation of Changes in Quality of LifeV1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,The EQ-5D-5L is a standardized instrument used to measure health outcomes. Developed by the EuroQol Group (EQ), it assesses five dimensions (5D) of health: Mobility Self-care Usual activities Pain/discomfort Anxiety/depression Each dimension has five levels (5L) of severity: no problems, slight problems, moderate problems, severe problems, and extreme problems
Evaluation of Patient Satisfaction by using PROMS: FJSV4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OPForgotten Joint Score (FJS) : A joint-specific questionnaire with the aim to measure PRO of joint disorders . FJS is designed to measure the ability of the patient to "forget" about their problematic joint after treatment. Scale: * 12 questions (How often are you aware of your affected knee joint in everyday life?) * 5-point response scale (0-4) * responses are then summed and divided by the number of completed items * mean value is then multiplied by 25 to obtain the total score of 0-100. A higher score indicates that the patient is less aware of their joint, suggesting better surgical outcomes and higher levels of patient satisfaction.
Anterior knee painV1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,Anterior knee pain is used to evaluate the performance of the implantation and the implant itself. Rating is classified according to the description of Waters and Bentley in four dimensions: 0 (no pain), I (Mild pain that does not intrude on daily activities), II (Moderate pain that is a nuisance; patient not considering further surgery), III (Severe pain; Patient considering further surgery). The scoring is according to Feller et al. 0, 5, 10 and 15 points, respectively. (Feller et al., J Bone Joint Surg Am. 2003 Feb;85(2):212-7).
Knee functional outcomeV4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OPRange of Motion (ROM)
Knee alignment, measurement of LDFA: Lateral distal femoral angleV4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OPLDFA: Lateral distal femoral angle. The angle between the mechanical axis of the femur and the knee joint line. Normal values typically range between 85° and 90° Medial proximal tibial angle (MPTA) and lateral distal femoral angle.
Knee alignment, measurement of MPTA: Medial proximal tibial angleV4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OPMPTA: Medial proximal tibial angle. The angle between the mechanical axis of the tibia and the knee joint line. Normal values also typically average around 87° ± 3°.
Knee alignment, measurement of HKA: Hip Knee AngleV4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OPHKA: (Hip Knee Angle). The mechanical angle between the center of the femoral head, the center of the knee, and the center of the ankle. It represents the overall lower limb alignment (e.g., neutral, varus, or valgus)
Radiologically relevant findings by using AIV4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP"Image biopsy lab" is a Digital AI platform that supports physicians and healthcare professionals in transforming medical imaging data into diagnostic findings.
Adverse eventsuntil end of study, up to 5 years.Serious and non-serious adverse events (SAE/AE)
Device deficiencies assessed by Adverse Eventsuntil end of study, up to 5 yearsIn any case of Adverse Events marked as "related to the product/device"
Intraoperative complicationsday of surgery
Survival of implant componentsFrom V3=Discharge to V7= 5 years post OP
Optional: OrthoPilot® DataDay of surgeryDuring surgery all data measured and stored by OrthoPilot® the computer assistant (e.g. time needed for the surgery, alignment of all implant components) will be evaluated.

Contacts

CONTACTHeike Oberascher
studies@aesculap.de+49 7461 95
CONTACTStefan Maenz, Dr.
studies@aesculap.de+49 7461 95
PRINCIPAL_INVESTIGATORAnne Postler, PD Dr. med

Städt. Klinikum Dresden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026